| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5699729 | Clinical Oncology | 2008 | 6 Pages |
Abstract
Intrapulmonary and brain metastases are seen more frequently at metastatic presentation in basal phenotype breast cancer patients, and the basal phenotype is associated with a poorer survival after metastatic presentation. Assessment of basal cytokeratin expression status may provide valuable prognostic information relevant to breast cancer patients' management.
Related Topics
Health Sciences
Medicine and Dentistry
Oncology
Authors
A.A. Luck, A.J. Evans, A.R. Green, E.A. Rakha, C. Paish, I.O. Ellis,